Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study

灵霉素 焦虑 医学 萧条(经济学) 精神科 癌症 心理健康 中止 医院焦虑抑郁量表 临床心理学 干预(咨询) 不利影响 物理疗法 苦恼 随机对照试验 心理干预 探索性研究 心理学 临床试验 焦虑症 定性研究
作者
Anthony L. Back,Bonnie A. McGregor,Leslie Lazar Thorn,Kelsey K. Baker,Ted Gooley,Mendel Kaelen,Kalin Harvey,J. Guy,Susanna Myers,Juliana Perez,Peter Thompson,Lindsay Billingsley,Cheryl Sesnon
出处
期刊: [Mary Ann Liebert, Inc.]
卷期号:4 (3): 209-221 被引量:6
标识
DOI:10.1177/28314425251413856
摘要

Background: Psilocybin is a promising therapy for cancer-related distress, but existing individual treatment models are resource intensive. In this study, we designed and tested a group model of psilocybin therapy for people with metastatic cancer and cancer-related anxiety and depression. Method: Eligibility criteria included metastatic cancer, moderate-to-severe symptoms of anxiety or depression without a pre-cancer mental health diagnosis, performance status adequate to attend a 3-day retreat that required self-care, and tapering of antidepressants. Exclusion criteria included enrollment in hospice. The design of the intervention included: two virtual preparatory sessions; a 3-day in-person retreat in a rustic setting that included the third prep session, the psilocybin session, and the first integration session; and two additional virtual integration sessions. Psilocybin was administered in oral capsules at 25 mg. A retreat team of four core facilitators and two backup facilitators conducted a series of eight retreats. The first retreat had five participants. For subsequent retreats, we used the primary safety outcome from each cohort, other safety outcomes, and qualitative feedback to make decisions to increase, decrease, or hold steady the participant number. The primary safety outcome was “unattended episodes of participant distress” during the psilocybin session requiring a backup facilitator. The primary exploratory efficacy outcome was reduction in anxiety and depression symptoms measured using the Hospital Anxiety and Depression Scale (HADS). Results: We enrolled 55 participants, of whom 3 withdrew prior to the retreat, leaving a total of 52. Their mean age was 53, and mean duration of living with cancer was 36 months, mean (range 5, 176); anticancer therapy was ongoing for 46 (88%); antidepressants were tapered for 18 (35%). The first retreat cohort had five participants, and the final retreat cohort had eight. For the primary safety outcome, there was not a single episode of unattended participant distress requiring a backup facilitator. The mean baseline at Day −14 (D −14) HADS total score was 17.5 (range 6–28); at D +28, the mean HADS total score was 10.2 (1–30), so the mean decrease in HADS from D −14 to D +28 was 7.3. ( p < 0.0001). Conclusion: The Group Retreat Psilocybin Therapy was safe and well tolerated, and exploratory measures show efficacy that is promising. A group configuration of eight participants with four core facilitators can be safe for future studies with participants with serious medical illness.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
酷酷酷发布了新的文献求助10
刚刚
1秒前
CodeCraft的应助被沾沾采纳,获得10
2秒前
哈喽啊完成签到,获得积分10
2秒前
xiaoqi666完成签到 ,获得积分0
3秒前
兰兰发布了新的文献求助10
3秒前
3秒前
3秒前
1440发布了新的文献求助10
3秒前
3秒前
坚定蘑菇发布了新的文献求助10
3秒前
4秒前
斯文明杰发布了新的文献求助10
5秒前
6秒前
7秒前
芦苇红柳给芦苇红柳的求助进行了留言
7秒前
8秒前
咕咕的鸽子完成签到 ,获得积分20
8秒前
Cynthia发布了新的文献求助10
8秒前
yzy发布了新的文献求助10
8秒前
Ava的应助被kqier采纳,获得10
8秒前
8秒前
9秒前
家若完成签到 ,获得积分10
9秒前
112233cc发布了新的文献求助10
10秒前
魔幻的访云完成签到,获得积分10
11秒前
科研通AI2S的应助被MrLiu采纳,获得10
11秒前
於依白发布了新的文献求助10
11秒前
lihui发布了新的文献求助10
11秒前
无花果的应助被Debbie采纳,获得10
12秒前
13秒前
大力思雁发布了新的文献求助10
15秒前
15秒前
顾矜的应助被mew桑采纳,获得10
15秒前
ewmmel发布了新的文献求助10
15秒前
ding的应助被嘛丝丝采纳,获得10
15秒前
112233cc完成签到,获得积分20
16秒前
於依白完成签到,获得积分10
17秒前
毛毛完成签到 ,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153710
求助须知:如何正确求助?哪些是违规求助? 9550475
关于积分的说明 21698625
捐赠科研通 7742521
什么是DOI,文献DOI怎么找? 3425571
关于科研通互助平台的介绍 2550735
邀请新用户注册赠送积分活动 2469211